Jeffrey R. Sachs, ScB, ScM, PhD, ACDRS

Distinguished Scientist, Exec. Dir.
Quantitative Pharmacology and PMX, Merck & Co., Inc., USA

Poster(s):

• (W-106) Comparing Predicted Serotype-specific Vaccine Effectiveness of Pneumococcal Conjugate Vaccines V114 and PCV20 in Children using a novel model-based meta-analysis approach
  Wednesday, November 13, 2024

  7:00 AM – 1:45 PM MST